The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenalidomide: Based maintenance after autologous hematopoietic stem cell transplant for patients with high-risk multiple myeloma.
 
Oren Pasvolsky
No Relationships to Disclose
 
Denai R. Milton
No Relationships to Disclose
 
Mikael Rauf
No Relationships to Disclose
 
Mark R. Tanner
No Relationships to Disclose
 
Qaiser Bashir
No Relationships to Disclose
 
Samer Ali Srour
No Relationships to Disclose
 
Neeraj Saini
No Relationships to Disclose
 
Jeremy L Ramdial
No Relationships to Disclose
 
Yago Nieto
Honoraria - Affimed Therapeutics
Research Funding - Affimed Therapeutics (Inst); AstraZeneca (Inst); Secura Bio (Inst)
 
Hans C. Lee
Consulting or Advisory Role - Bristol Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Immunitas; Karyopharm Therapeutics; Legend Biotech; Monte Rosa Therapeutics; Oncopeptides; Pfizer; Sanofi; Takeda
Research Funding - Amgen; Celgene; GlaxoSmithKline; Janssen; Regeneron; Takeda
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Pfizer
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Partow Kebriaei
Honoraria - Kite, a Gilead company; Novartis; Pfizer
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Amgen; ZIOPHARM Oncology
Travel, Accommodations, Expenses - Kite, a Gilead company; Novartis; Pfizer
 
Sheeba K. Thomas
No Relationships to Disclose
 
Donna M. Weber
No Relationships to Disclose
 
Robert Z. Orlowski
Stock and Other Ownership Interests - Asymmetric Therapeutics
Honoraria - Abbvie; BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; Karyopharm Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Neoleukin Therapeutics; Oncopeptides; Regeneron; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; Karyopharm Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Neoleukin Therapeutics; Oncopeptides; Regeneron; Sanofi; Takeda
Research Funding - Asymmetric Therapeutics (Inst); BioTheryX (Inst); Heidelberg Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Asymmetric Therapeutics
 
Elizabeth J. Shpall
Honoraria - Bayer
Consulting or Advisory Role - • Bayer HealthCare Pharmaceuticals; Adaptimmune; AXIO Research; Fibrobiologics; Navan
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics; Takeda
Travel, Accommodations, Expenses - Magenta Therapeutics; Novartis
 
Richard E. Champlin
Consulting or Advisory Role - Actinium Pharmaceuticals; Arog; Johnson & Johnson/Janssen; Kadmon; Omeros
Patents, Royalties, Other Intellectual Property - Royalty from Takeda Corporation
 
Muzaffar H. Qazilbash
Consulting or Advisory Role - Bristol-Myers Squibb; Oncopeptides
Research Funding - Amgen (Inst); Angiocrine Bioscience (Inst); BioLineRx (Inst); Janssen (Inst); NexImmune (Inst)